Partners Jenscare Scientific Co., Ltd. (HKG: 9877), a leading structural heart disease device manufacturer based in Ningbo, and Lifetech Scientific Corporation (HKG: 1302) have successfully accomplished the first compassionate use case utilizing Jenscare’s transjugular tricuspid valve replacement product, LuX-Valve Plus, in Hong Kong.
Understanding Compassionate Use
Compassionate use, also referred to as expanded access, is a practice that allows patients who are otherwise ineligible to participate in a specific clinical trial to gain access to a drug or device through the host hospital. This provision is typically reserved for patients enduring life-threatening conditions or those whose quality of life is severely compromised.
Significance of the Compassionate Use Case
The successful implementation of the first compassionate use case with LuX-Valve Plus marks a significant milestone for both Jenscare Scientific and Lifetech Scientific. It demonstrates the potential of their collaborative efforts in providing advanced structural heart disease solutions and underscores the humanitarian aspect of making life-saving treatments accessible to patients in dire need.-Fineline Info & Tech
